Dioctyl Terephthalate From South Korea, 42103-42104 [2023-13862]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 124 / Thursday, June 29, 2023 / Notices
identifying information from public
review, ONRR cannot guarantee that it
will be able to do so.
Abstract: (a) General Information:
ONRR issues orders and assesses civil
penalties in performing mineral revenue
management responsibilities for the
Secretary of the Interior. See U.S.
Department of the Interior Departmental
Manual, 112 DM 34.1 (Sept. 9, 2020). A
person who timely appeals an ONRR
order may post a bond or other surety
instrument pursuant to 30 CFR part
1243, or, for Federal leases, demonstrate
financial solvency pursuant to 30 CFR
part 1243, subpart C, to suspend its
compliance with the order during the
appeal. See 30 CFR 1243.1. Similarly, if
an administrative law judge determines
that a stay is warranted, the recipient of
a civil penalty notice who timely
requests a hearing may post a surety
instrument or demonstrate financial
solvency under these same subparts to
stay the assessment or accrual of
penalties pending a hearing on the
record and decision by the
administrative law judge. See 30 CFR
1241.11.
(b) Information Collections: ONRR
accepts the following surety types: Form
ONRR–4435, Administrative Appeal
Bond; Form ONRR–4436, Letter of
Credit; Form ONRR–4437, Assignment
of Certificate of Deposit; Self-bonding;
and U.S. Treasury Securities. See 30
CFR 1210.157. Instructions for
submitting these surety instruments or
self-bonding are located at https://
www.onrr.gov/document/SuretyInst.pdf.
This ICR covers the burden hours
associated with submitting surety
instruments and self-bonding pursuant
to 30 CFR part 1243 as follows:
(1) Form ONRR–4435, Administrative
Appeal Bond: A person using this form
of surety supplies various information
on the form ONRR–4435, such as its
contact information, surety company
name and address, and surety amount.
The bond must be issued by a qualified
surety company approved by the U.S.
Department of the Treasury (see
Department of the Treasury Circular No.
570, revised periodically in the Federal
Register). ONRR maintains the bond in
a secure facility.
(2) Form ONRR–4436, Letter of Credit:
A person using this form of surety must
complete the form ONRR–4436, with no
modifications. The person supplies
various information on the form, such as
bank name and address, bank ABA
number, and effective date. ONRR
maintains the letter of credit in a secure
facility. The person submitting the letter
of credit is responsible for verifying that
the bank provides a current Fitch rating
to ONRR.
VerDate Sep<11>2014
17:21 Jun 28, 2023
Jkt 259001
(3) Form ONRR–4437, Assignment of
Certificate of Deposit: A person seeking
to use a Certificate of Deposit (CD) as
surety must submit a written request to
ONRR to do so. A person using this
form of surety supplies various
information on the form ONRR–4437,
such as the CD number, CD amount, and
bank name. ONRR will accept only a
book-entry CD that explicitly assigns the
CD to ONRR’s Director.
(4) U.S. Treasury Securities: A person
seeking to use a U.S. Treasury Security
(‘‘TS’’) as surety must submit a written
request to ONRR to do so. The TS must
be a U.S. Treasury note or bond with
maturity equal to or greater than one
year. The TS must equal 120 percent of
the appealed amount plus 1 year of
estimated interest (necessary to protect
ONRR against interest rate fluctuations).
ONRR only accepts a book-entry TS.
(5) Self-bonding: For Federal oil and
gas leases only (not Indian leases), 30
CFR 1243.201 provides that no surety
instrument is required when a person
periodically demonstrates, to the
satisfaction of ONRR, that it is
financially solvent or otherwise able to
pay the obligation. ONRR requires the
person to submit a consolidated balance
sheet, subject to annual audit. In some
cases, ONRR also requires copies of the
most recent tax returns (up to three
years).
In addition, the person must annually
submit financial statements, subject to
audit, to support its net worth. If the
person does not have a consolidated
balance sheet documenting its net
worth, or if it does not meet the $300
million net worth requirement, ONRR
will select a business information or
credit reporting service to provide
information concerning its financial
solvency. ONRR charges a $50 fee each
time it reviews data from a business
information or credit reporting service.
The fee covers ONRR’s cost to
determine financial solvency.
Title of Collection: Suspensions
Pending Appeal and Bonding.
OMB Control Number: 1012–0006.
Form Number: Forms ONRR–4435,
ONRR–4436, and ONRR–4437.
Type of Review: Extension of a
currently approved collection.
Respondents/Affected Public:
Businesses.
Total Estimated Number of Annual
Respondents: 105 Federal or Indian
appellants.
Total Estimated Number of Annual
Responses: 105.
Estimated Completion Time per
Response: 2 hours.
Total Estimated Number of Annual
Burden Hours: 210.
Respondent’s Obligation: Mandatory.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
42103
Frequency of Collection: Annual and
on occasion.
Total Estimated Annual Non-hour
Burden Cost: There are no additional
recordkeeping costs associated with this
information collection. However, ONRR
estimates 5 appellants per year will pay
a $50 fee to obtain credit data from a
business information or credit reporting
service, which is a total ‘‘non-hour’’ cost
burden of $250 per year (5 appellants
per year $50 = $250).
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid OMB
control number.
The authority for this action is the
PRA (44 U.S.C. 3501 et seq.).
Howard Cantor,
Director, Office of Natural Resources
Revenue.
[FR Doc. 2023–13867 Filed 6–28–23; 8:45 am]
BILLING CODE 4335–30–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 731–TA–1330 (Review)]
Dioctyl Terephthalate From South
Korea
Determination
On the basis of the record 1 developed
in the subject five-year review, the
United States International Trade
Commission (‘‘Commission’’)
determines, pursuant to the Tariff Act of
1930 (‘‘the Act’’), that revocation of the
antidumping duty order on dioctyl
terephthalate from South Korea would
be likely to lead to continuation or
recurrence of material injury to an
industry in the United States within a
reasonably foreseeable time.
Background
The Commission instituted this
review on July 1, 2022 (87 FR 39556)
and determined on October 4, 2022 that
it would conduct a full review (87 FR
75067, December 7, 2022). Notice of the
scheduling of the Commission’s review
and of a public hearing to be held in
connection therewith was given by
posting copies of the notice in the Office
of the Secretary, U.S. International
Trade Commission, Washington, DC,
and by publishing the notice in the
Federal Register on December 22, 2022
(87 FR 78708). Since one party
requested cancellation of a hearing and
no other parties requested a hearing, the
1 The record is defined in § 207.2(f) of the
Commission’s Rules of Practice and Procedure (19
CFR 207.2(f)).
E:\FR\FM\29JNN1.SGM
29JNN1
42104
Federal Register / Vol. 88, No. 124 / Thursday, June 29, 2023 / Notices
public hearing in connection with the
review, originally scheduled for April
27, 2023, was cancelled (88 FR 26598,
April 25, 2023).
The Commission made this
determination pursuant to section
751(c) of the Act (19 U.S.C. 1675(c)). It
completed and filed its determination in
this review on June 26, 2023. The views
of the Commission are contained in
USITC Publication 5433 (June 2023),
entitled Dioctyl Terephthalate from
South Korea: Investigation No. 731–TA–
1330 (Review).
By order of the Commission.
Issued: June 26, 2023.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2023–13862 Filed 6–28–23; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1197]
Importer of Controlled Substances
Application: Irvine Labs, Inc.
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Irvine Labs, Inc. has applied
to be registered as an importer of basic
class(es) of controlled substance(s).
Refer to Supplementary Information
listed below for further drug
information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before July 31, 2023. Such persons
may also file a written request for a
hearing on the application on or before
July 31, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
SUMMARY:
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
In
accordance with 21 CFR 1301.34(a), this
is notice that on April 20, 2023, Irvine
Labs, Inc. 7305 Murdy Circle,
Huntington Beach, California 92647–
3533, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s).
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
lotter on DSK11XQN23PROD with NOTICES1
Lysergic acid diethylamide ....................................................................................................................................................
Marihuana Extract .................................................................................................................................................................
Marihuana ..............................................................................................................................................................................
Tetrahydrocannabinols ..........................................................................................................................................................
Mescaline ...............................................................................................................................................................................
Peyote ....................................................................................................................................................................................
Diethyltryptamine ...................................................................................................................................................................
Dimethyltryptamine ................................................................................................................................................................
Psilocybin ...............................................................................................................................................................................
Psilocyn .................................................................................................................................................................................
The company plans to import the bulk
substances to support internal research,
clinical trials, analytical purposes, and
distribution to their customers. In
reference to drug codes 7360
(Marihuana), 7350 (Marihuana Extract),
and 7370 (Tetrahydrocannabinols) the
company plans to import a raw plant
material and extracts. No other activities
for these drug codes are authorized for
this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or non-
VerDate Sep<11>2014
17:43 Jun 28, 2023
Jkt 259001
approved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–13812 Filed 6–28–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF LABOR
Office of Workers’ Compensation
Programs
[OMB Control No. 1240–0021]
Proposed Extension of Existing
Collection; Comment Request
Office of Workers’
Compensation Programs, Labor.
ACTION: Request for public comment.
AGENCY:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
7315
7350
7360
7370
7381
7415
7434
7435
7437
7438
Schedule
I
I
I
I
I
I
I
I
I
I
The Department of Labor, as
part of its continuing effort to reduce
paperwork and respondent burden,
conducts a pre-clearance request for
comment to provide the general public
and Federal agencies with an
opportunity to comment on proposed
collections of information in accordance
with the Paperwork Reduction Act of
1995. This request helps to ensure that:
requested data can be provided in the
desired format; reporting burden (time
and financial resources) is minimized;
collection instruments are clearly
understood; and the impact of collection
requirements on respondents can be
properly assessed. Currently, OWCP is
soliciting comments on the information
collection for the Provider Enrollment
Form (PE–1168).
DATES: All comments must be received
on or before August 28, 2023.
SUMMARY:
E:\FR\FM\29JNN1.SGM
29JNN1
]]>Agencies
[Federal Register Volume 88, Number 124 (Thursday, June 29, 2023)]
[Notices]
[Pages 42103-42104]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-13862]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 731-TA-1330 (Review)]
Dioctyl Terephthalate From South Korea
Determination
On the basis of the record \1\ developed in the subject five-year
review, the United States International Trade Commission
(``Commission'') determines, pursuant to the Tariff Act of 1930 (``the
Act''), that revocation of the antidumping duty order on dioctyl
terephthalate from South Korea would be likely to lead to continuation
or recurrence of material injury to an industry in the United States
within a reasonably foreseeable time.
---------------------------------------------------------------------------
\1\ The record is defined in Sec. 207.2(f) of the Commission's
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------
Background
The Commission instituted this review on July 1, 2022 (87 FR 39556)
and determined on October 4, 2022 that it would conduct a full review
(87 FR 75067, December 7, 2022). Notice of the scheduling of the
Commission's review and of a public hearing to be held in connection
therewith was given by posting copies of the notice in the Office of
the Secretary, U.S. International Trade Commission, Washington, DC, and
by publishing the notice in the Federal Register on December 22, 2022
(87 FR 78708). Since one party requested cancellation of a hearing and
no other parties requested a hearing, the
[[Page 42104]]
public hearing in connection with the review, originally scheduled for
April 27, 2023, was cancelled (88 FR 26598, April 25, 2023).
The Commission made this determination pursuant to section 751(c)
of the Act (19 U.S.C. 1675(c)). It completed and filed its
determination in this review on June 26, 2023. The views of the
Commission are contained in USITC Publication 5433 (June 2023),
entitled Dioctyl Terephthalate from South Korea: Investigation No. 731-
TA-1330 (Review).
By order of the Commission.
Issued: June 26, 2023.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2023-13862 Filed 6-28-23; 8:45 am]
BILLING CODE 7020-02-P
